Enanta Pharma (ENTA) Tops Q3 EPS by 36c
Tweet
Share
E-mailGet Alerts ENTA Hot Sheet
Join SI Premium – FREE
Enanta Pharma (NASDAQ: ENTA) reported Q3 EPS of ($1.07), $0.36 better than the analyst estimate of ($1.43). Revenue for the quarter came in at $18 million versus the consensus estimate of $17.44 million.
For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- American Outdoor Brands (AOUT) Tops Q4 EPS by 14c
- Starwood Property Trust prices $500M sustainability bond offering
- SanDisk stock target lifted by Citi on continued demand strength
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
